Return to home page
Searching: Muskingum library catalog
Some OPAL libraries remain closed or are operating at reduced service levels. Materials from those libraries may not be requestable; requested items may take longer to arrive. Note that pickup procedures may differ between libraries. Please contact your library for new procedures, specific requests, or other assistance.
  Previous Record Previous Item Next Item Next Record
  Reviews, Summaries, etc...
EBOOK
Title Microdomains in the cardiovascular system / Viacheslav Nikolaev, Manuela Zaccolo, editors.
Imprint Cham : Springer, 2017.

LOCATION CALL # STATUS MESSAGE
 OHIOLINK SPRINGER EBOOKS    ONLINE  
View online
LOCATION CALL # STATUS MESSAGE
 OHIOLINK SPRINGER EBOOKS    ONLINE  
View online
Series Cardiac and vascular biology, 2509-7830
Cardiac and vascular biology.
Subject Cardiovascular system -- Physiology.
Cardiovascular system -- Molecular aspects.
Human physiology.
Cytology.
Pharmacology.
Alt Name Nikolaev, Viacheslav.
Zaccolo, Manuela.
Description 1 online resource.
Bibliography Note Includes bibliographical references.
Contents Preface; Contents; Part I: Cyclic Nucleotide Microdomains; 1: Receptor-Cyclic Nucleotide Microdomains in the Heart; 1.1 Introduction; 1.2 Biosensors for cAMP and cGMP; 1.3 Mechanisms of Compartmentation in Microdomains; 1.4 Receptor-cAMP/cGMP Microdomain Visualization; References; 2: Membrane Microdomains and cAMP Compartmentation in Cardiac Myocytes; 2.1 Introduction; 2.2 Membrane Microdomains; 2.3 Receptor-Mediated Responses; 2.3.1 1-Adrenergic Receptors (1ARs); 2.3.2 2-Adrenergic Receptors (2ARs); 2.3.3 M2 Muscarinic Receptors (M2Rs); 2.3.4 Prostaglandin Receptors (EPRs).
5: Chatting Second Messengers: PIP3 and cAMP; 5.1 Introduction; 5.2 PIP3: A Signaling Lipid on Membranes; 5.3 Mechanisms of Cross-Talk between PIP3 and cAMP Signaling; 5.3.1 PIP3-Mediated Downregulation of -AR/cAMP Signaling in Heart Failure; 5.3.2 PIP3- and PI3K-Dependent Control of cAMP Hydrolysis; 5.3.3 cAMP-Mediated Regulation of PIP3 Signaling; References; 6: Cyclic Nucleotide Phosphodiesterases and Compartmentation in Normal and Diseased Heart; 6.1 Introduction; 6.2 CN Signalling in Cardiac Myocytes; 6.3 Overview of the PDE Superfamily.
2.4 Conclusions and Future Directions; References; 3: Function to Failure: Compartmentalization of Cardiomyocyte Signaling by A-Kinase-Anchoring Proteins; 3.1 Introduction; 3.2 AKAPs and Regulation of the Calcium Cycle; 3.2.1 AKAP7 (Small Isoforms); 3.2.2 AKAP7 (Large); 3.2.3 AKAP5 (AKAP75/AKAP79/AKAP150); 3.3 AKAPs and Cardiac Remodeling; 3.3.1 AKAP6; 3.3.2 AKAP13; 3.4 Other AKAPs with Characterized Functions; References; 4: Pharmacological Approaches for Delineating Functions of AKAP-Based Signalling Complexes and Finding Therapeutic Targets; 4.1 Introduction.
4.1.1 The cAMP Signalling Cascade; 4.1.2 cAMP Effectors; 4.1.3 cAMP Signalling Compartments; 4.2 A-Kinase Anchoring Proteins (AKAPs); 4.2.1 AKAP-PKA Interactions; 4.2.2 The Role of AKAPs in the Heart and Cardiovascular Diseases Exemplifies Their Potential Value as Drug Targets; 4.3 AKAP-PKA Disruptors; 4.3.1 Peptides; 4.3.1.1 Binding to R-Subunits of PKA; 4.3.1.2 Binding to AKB Domains of AKAPs; 4.3.1.3 Modified Peptides; 4.3.2 Peptidomimetics; 4.3.3 Small Molecules; 4.3.4 Disruptors of Interaction Between AKAPs and Proteins Other Than PKA; 4.4 Conclusions and Outlook; References.
6.4 Role of PDEs in Cyclic Nucleotide Compartmentation; 6.5 PDEs and Cyclic Nucleotide Compartmentation in Heart Failure; 6.6 PDEs as Therapeutic Targets in Ischemia/Reperfusion Injury?; 6.7 Concluding Remarks; References; 7: cAMP Compartmentalisation and Hypertrophy of the Heart: 'Good' Pools of cAMP and 'Bad' Pools of cAMP Coexist in the Same Cardiac Myocyte; 7.1 cAMP Signalling in the Heart; 7.2 Compartmentalisation of the cAMP Signalling Pathway; 7.3 Compartmentalisation of GPCRs and ACs; 7.4 PKA Compartmentalisation via AKAPs; 7.5 PDEs and cAMP Compartmentalisation.
Summary The book comprehensively presents new findings in cardiovascular research related to signaling microdomains in health and disease. Important second messengers such as cAMP, cGMP, calcium and their role in microdomain signaling are discussed. The book offers and explains methodical approaches and technical ways how to successfully analyze microdomain signaling, also in the context of disease. It further provides scientific perspectives and strategies that are based on the concept of signaling within microdomains and that can revolutionize pharmacology and eventually lead to the effective treatment of cardiovascular diseases in future. This book is written for scientists in cardiovascular research, pharmacology, molecular and cellular biology as well as medical doctors in cardiology, angiology and nephrology.
Note Print version record.
ISBN 9783319545790 (electronic bk.)
3319545795 (electronic bk.)
9783319545783
3319545787
ISBN/ISSN 10.1007/978-3-319-54579-0
OCLC # 1004725596
Additional Format Print version: Microdomains in the cardiovascular system. Cham : Springer, 2017 3319545787 9783319545783 (OCoLC)971041303


If you experience difficulty accessing or navigating this content, please contact the OPAL Support Team